$235.99 Million in Sales Expected for Medical Properties Trust, Inc. (NYSE:MPW) This Quarter

Equities analysts predict that Medical Properties Trust, Inc. (NYSE:MPW) will post $235.99 million in sales for the current quarter, Zacks reports. Seven analysts have made estimates for Medical Properties Trust’s earnings, with the lowest sales estimate coming in at $192.55 million and the highest estimate coming in at $258.68 million. Medical Properties Trust reported sales of $180.58 million in the same quarter last year, which would suggest a positive year over year growth rate of 30.7%. The company is scheduled to issue its next quarterly earnings results on Thursday, February 6th.

According to Zacks, analysts expect that Medical Properties Trust will report full-year sales of $823.51 million for the current financial year, with estimates ranging from $758.10 million to $852.52 million. For the next financial year, analysts forecast that the firm will post sales of $1.01 billion, with estimates ranging from $770.20 million to $1.18 billion. Zacks’ sales calculations are an average based on a survey of analysts that that provide coverage for Medical Properties Trust.

Medical Properties Trust (NYSE:MPW) last released its quarterly earnings results on Thursday, October 31st. The real estate investment trust reported $0.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.12). The company had revenue of $224.70 million for the quarter, compared to the consensus estimate of $221.40 million. Medical Properties Trust had a return on equity of 6.36% and a net margin of 41.57%. The business’s revenue was up 14.1% compared to the same quarter last year. During the same quarter last year, the company posted $0.35 EPS.

Several research firms have recently issued reports on MPW. Berenberg Bank began coverage on Medical Properties Trust in a research note on Thursday, September 12th. They set a “buy” rating and a $22.00 price target for the company. SunTrust Banks upped their price target on Medical Properties Trust from $20.00 to $21.00 and gave the stock a “buy” rating in a research note on Tuesday, August 27th. Bank of America began coverage on Medical Properties Trust in a research note on Monday, October 14th. They set a “neutral” rating and a $19.50 price target for the company. Stifel Nicolaus set a $21.00 price target on Medical Properties Trust and gave the stock a “buy” rating in a research note on Monday, August 12th. Finally, Barclays set a $22.00 price target on Medical Properties Trust and gave the stock a “buy” rating in a research note on Monday, October 21st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $20.18.

In other news, CFO R Steven Hamner sold 77,500 shares of the stock in a transaction that occurred on Wednesday, September 25th. The stock was sold at an average price of $19.43, for a total value of $1,505,825.00. Following the completion of the transaction, the chief financial officer now directly owns 1,235,457 shares of the company’s stock, valued at approximately $24,004,929.51. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Edward K. Aldag, Jr. sold 101,964 shares of the stock in a transaction that occurred on Thursday, October 10th. The stock was sold at an average price of $19.78, for a total value of $2,016,847.92. Following the completion of the transaction, the chief executive officer now directly owns 2,058,820 shares of the company’s stock, valued at $40,723,459.60. The disclosure for this sale can be found here. Insiders sold a total of 279,464 shares of company stock valued at $5,359,673 in the last quarter. Corporate insiders own 1.18% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of the company. Cetera Investment Advisers raised its holdings in shares of Medical Properties Trust by 3.1% in the 3rd quarter. Cetera Investment Advisers now owns 30,204 shares of the real estate investment trust’s stock worth $592,000 after buying an additional 908 shares in the last quarter. First Allied Advisory Services Inc. raised its holdings in shares of Medical Properties Trust by 54.8% in the 3rd quarter. First Allied Advisory Services Inc. now owns 24,401 shares of the real estate investment trust’s stock worth $481,000 after buying an additional 8,636 shares in the last quarter. Miracle Mile Advisors LLC raised its holdings in shares of Medical Properties Trust by 13.8% in the 3rd quarter. Miracle Mile Advisors LLC now owns 26,575 shares of the real estate investment trust’s stock worth $520,000 after buying an additional 3,225 shares in the last quarter. Northwestern Mutual Investment Management Company LLC raised its holdings in shares of Medical Properties Trust by 13.1% in the 3rd quarter. Northwestern Mutual Investment Management Company LLC now owns 127,254 shares of the real estate investment trust’s stock worth $2,489,000 after buying an additional 14,766 shares in the last quarter. Finally, HGI Capital Management LLC acquired a new position in shares of Medical Properties Trust in the 3rd quarter worth approximately $2,825,000. 71.66% of the stock is owned by institutional investors and hedge funds.

MPW opened at $19.95 on Friday. The company has a market cap of $8.56 billion, a PE ratio of 14.56, a price-to-earnings-growth ratio of 3.39 and a beta of 0.52. The stock has a 50-day moving average of $19.84 and a 200-day moving average of $18.53. Medical Properties Trust has a 52-week low of $15.25 and a 52-week high of $20.92. The company has a debt-to-equity ratio of 1.02, a quick ratio of 8.00 and a current ratio of 6.27.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 10th. Shareholders of record on Thursday, September 12th were given a $0.26 dividend. The ex-dividend date of this dividend was Wednesday, September 11th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 5.21%. This is an increase from Medical Properties Trust’s previous quarterly dividend of $0.25. Medical Properties Trust’s dividend payout ratio (DPR) is currently 75.91%.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Further Reading: How to start trading in the forex market?

Get a free copy of the Zacks research report on Medical Properties Trust (MPW)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.